CRBU
Price
$1.23
Change
+$0.01 (+0.82%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
131.87M
39 days until earnings call
Intraday BUY SELL Signals
GERN
Price
$1.20
Change
-$0.01 (-0.83%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
803.09M
40 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CRBU vs GERN

CRBU vs GERN Comparison Chart in %
View a ticker or compare two or three
VS
CRBU vs. GERN commentary
Oct 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBU is a Hold and GERN is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
GERN: Fundamental Ratings
GERN
OUTLOOK RATING
1..100
60
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
77
P/E GROWTH RATING
1..100
60
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRBUGERN
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
N/A
Declines
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 2 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
COMPARISON
Comparison
Oct 02, 2026
Stock price -- (CRBU: $1.22 vs. GERN: $1.21)
Brand notoriety: CRBU and GERN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBU: 62% vs. GERN: 110%
Market capitalization -- CRBU: $131.87M vs. GERN: $803.09M
CRBU [@Biotechnology] is valued at $131.87M. GERN’s [@Biotechnology] market capitalization is $803.09M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBU’s FA Score shows that 1 FA rating(s) are green while GERN’s FA Score has 0 green FA rating(s).

  • CRBU’s FA Score: 1 green, 4 red.
  • GERN’s FA Score: 0 green, 5 red.
According to our system of comparison, CRBU is a better buy in the long-term than GERN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBU’s TA Score shows that 5 TA indicator(s) are bullish while GERN’s TA Score has 3 bullish TA indicator(s).

  • CRBU’s TA Score: 5 bullish, 4 bearish.
  • GERN’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, CRBU is a better buy in the short-term than GERN.

Price Growth

CRBU (@Biotechnology) experienced а -2.40% price change this week, while GERN (@Biotechnology) price change was -3.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.63%. For the same industry, the average monthly price growth was -14.35%, and the average quarterly price growth was -1.64%.

Reported Earning Dates

CRBU is expected to report earnings on Nov 10, 2026.

GERN is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Biotechnology (-3.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
CRBU
Daily Signal:
Gain/Loss:
GERN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LPLA312.156.35
+2.08%
LPL Financial Holdings
MWA21.500.26
+1.22%
Mueller Water Products
LANV1.05N/A
-0.47%
Lanvin Group Holdings Limited
VSTM7.90-0.15
-1.86%
Verastem
FEBO0.65-0.02
-2.86%
Fenbo Holdings Limited